- KR₩87bn
- KR₩205bn
- KR₩367bn
Annual balance sheet for JC Chemical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17,187 | 13,901 | 9,025 | 21,037 | 30,352 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17,411 | 37,543 | 50,287 | 28,115 | 28,975 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 76,623 | 141,810 | 127,727 | 117,936 | 118,756 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 124,072 | 130,478 | 127,940 | 130,319 | 153,000 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 240,970 | 320,805 | 308,044 | 300,138 | 331,844 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 85,625 | 154,048 | 126,795 | 109,004 | 131,906 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 139,766 | 189,474 | 160,564 | 135,321 | 168,053 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 101,204 | 131,332 | 147,481 | 164,817 | 163,791 |
Total Liabilities & Shareholders' Equity | 240,970 | 320,805 | 308,044 | 300,138 | 331,844 |
Total Common Shares Outstanding |